EMA recommends restrictions on Merck, Roche immunotherapies
ZURICH (Reuters) - The European Medicines Agency on Friday recommended restricting use of two immunotherapies, one from Roche and the other from Merck, in initial bladder cancer treatment, saying they may not work as well as chemotherapy in some patients.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Bladder Cancer | Cancer | Cancer & Oncology | Chemotherapy | European Medicines Agency (EMA) | Health | Immunotherapy | Merck